Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T07279 | Target Info | |||
Target Name | Serine/threonine-protein kinase pim-2 (PIM2) | ||||
Synonyms | Pim-2h; PIM2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | PIM2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: 2-(2,6-Difluorophenyl)-N-{4-[(3s)-Pyrrolidin-3-Yloxy]pyridin-3-Yl}-1,3-Thiazole-4-Carboxamide | Ligand Info | |||||
Structure Description | PIM2 kinase in complex with Compound 1s | PDB:4X7Q | ||||
Method | X-ray diffraction | Resolution | 2.33 Å | Mutation | No | [1] |
PDB Sequence |
AFEAEYRLGP
36 LLGKGFGTVF47 AGHRLTDRLQ57 VAIKVIPRCP81 LEVALLWKVG91 AGGGHPGVIR 101 LLDWFETFML114 VLERPLPAQD124 LFDYITEKGP134 LGEGPSRCFF144 GQVVAAIQHC 154 HSRGVVHRDI164 KDENILIDLR174 RGCAKLIDFG184 SGALLHDEPY194 TDFDGTRVYS 204 PPEWISRHQY214 HALPATVWSL224 GILLYDMVCG234 DIPFERDQEI244 LEAELHFPAH 254 VSPDCCALIR264 RCLAPKPSSR274 PSLEEILLDP284 WMQ
|
|||||
|
||||||
Ligand Name: Ruthenium-pyridocarbazole-1 | Ligand Info | |||||
Structure Description | CRYSTAL STRUCTURE OF THE HUMAN PIM2 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1 | PDB:2IWI | ||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | No | [2] |
PDB Sequence |
YRLGPLLGKG
41 GFGTVFAGHR51 LTDRLQVAIK61 VIPRNRVLVT79 CPLEVALLWK89 VGAGGGHPGV 99 IRLLDWFFML114 VLERPLPAQD124 LFDYITEKGP134 LGEGPSRCFF144 GQVVAAIQHC 154 HSRGVVHRDI164 KDENILIDLR174 RGCAKLIDFG184 SGALLHDEPY194 TDFDGTRVYS 204 PPEWISRHQY214 HALPATVWSL224 GILLYDMVCG234 DIPFERDQEI244 LEAELHFPAH 254 VSPDCCALIR264 RCLAPKPSSR274 PSLEEILLDP284 WMQT
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structure-based design of low-nanomolar PIM kinase inhibitors. Bioorg Med Chem Lett. 2015 Feb 1;25(3):474-80. | ||||
REF 2 | Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor. PLoS One. 2009 Oct 20;4(10):e7112. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.